Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27517394 | 0.98 | MAPT (0.61) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL6921083 | 0.88 | ALDH1A1 (0.81) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL6982143 | 0.88 | MAPT (0.52) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL725810 | 0.87 | ALDH1A1 (0.75) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL9725073 | 0.84 | ALDH1A1 (0.66) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| Thiourea SCHEMBL1991944 | 0.84 | MAPT (0.73) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL10189868 | 0.81 | EPHX1 (0.60) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL5445907 | 0.80 | MAPT (0.75) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL8956455 | 0.80 | MAPT (0.75) | MAPTKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL4395392 | 0.80 | MAPT (0.61) | MAPTKDM4EALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462459-B | Low-sensitization epoxy resin curing agent and preparation method thereof | 安徽美东生物材料有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119462459-A | Low-sensitization epoxy resin curing agent and preparation method thereof | 安徽美东生物材料有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115532081-A | Acid-resistant positive charge nanofiltration composite membrane and preparation method thereof | 广东奥斯博膜材料技术有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-114432901-A | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-103373969-A | Phenyl imidazole ring-substituted amide compounds as well as preparation method and application for same | SHANGHAI INST ORGANIC CHEM | 2013-10-30 | — | — | CN | claimed |
| CN-101687816-A | Triaminopyrimidine derivatives as the CDC25 inhibitors of phosphatases | IPSEN PHARMA SAS | 2010-03-31 | — | — | CN | claimed |
| US-4363913-A | Preparation of 2-aminobenzothiazoles | EASTMAN KODAK COMPANY (US) | 1982-12-14 | — | — | US | claimed |
| EP-4629980-A1 | ANTIMICROBIAL COMPOUNDS | SRI International (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-06-12 | — | — | US | disclosed |
| CN-119462459-B | Low-sensitization epoxy resin curing agent and preparation method thereof | 安徽美东生物材料有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20250092020-A1 | IDO/TDO Inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| CN-119462459-A | Low-sensitization epoxy resin curing agent and preparation method thereof | 安徽美东生物材料有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12209079-B2 | IDO/TDO inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-01-28 | — | — | US | disclosed |
| US-4657632-A | CONTAINING A THIOUREA AND A UREA COMPOUND | TECHNO INSTRUMENTS INVESTMENTS 1983 LTD. (IL) | 1987-04-14 | — | — | US | disclosed |
| EP-0216531-A1 | Use of immersion tin and tin alloys as a bonding medium for multilayer circuits | TECHNO INSTRUMENTS INVESTMENTS 1983 LTD. (IL) | 1987-04-01 | — | — | EP | disclosed |
| US-4563533-A | FROM CORRESPONDING PHENYLTHIOUREAS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-01-07 | — | — | US | disclosed |
| EP-0152021-A2 | Phthalimide derivatives, their preparation and their use as agricultural fungicides | SANKYO COMPANY LIMITED (JP) | 1985-08-21 | — | — | EP | disclosed |
| US-4363913-A | Preparation of 2-aminobenzothiazoles | EASTMAN KODAK COMPANY (US) | 1982-12-14 | — | — | US | disclosed |
| US-4148657-A | WEAR RESISTANCE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148799-A | Process for the preparation of 2-aryliminothiazoline solutions | BAYER AKTIENGESELLSCHAFT (DE) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209079-B2 | IDO/TDO inhibitor | IDO1, IDO2, TDO2 | MAPT 609/4885KDM4E 1315/4885ALDH1A1 3331/4885 |
| US-20250092020-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | MAPT 609/4885KDM4E 1315/4885ALDH1A1 3331/4885 |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | KLK3, BRDT, ACP3 | MAPT 2614/4885KDM4E 1179/4885ALDH1A1 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.